Search research articles
Contact Us
Filters
Showing results (421-430 of 462) with videos related to
Page
of 47
Sort By:
American Journal of Physiology. Renal Physiology
|
August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
Timothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 28, 2017
[Prediction of outcome in acute myeloid leukemia by measurement of WT1 expression as a basic marker of minimal residual disease]
N Zhao, H Wei, Y Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications
Timothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Chemical Science
|
February 3, 2015
Kinetically Selective Inhibitors of Histone Deacetylase 2 (HDAC2) as Cognition Enhancers
F F Wagner, Y-L Zhang, D M Fass, et al.
British Journal of Cancer
|
June 28, 2012
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer
N Zhao, M-K Ang, X-Y Yin, et al.
Plos One
|
June 7, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
Kathleen M C Sullivan, Marta Vilalta, Linda S Ertl, et al.
European Journal of Clinical Nutrition
|
January 29, 2015
Folic acid supplementation and dietary folate intake, and risk of preeclampsia
Y Wang, N Zhao, J Qiu, et al.
Physical Review Letters
|
May 27, 2014
New edge coherent mode providing continuous transport in long-pulse H-mode plasmas
H Q Wang, G S Xu, B N Wan, et al.
Nature
|
January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
Masataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
Nature
|
November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Page
of 47
Search research articles
Search
Showing results (421-430 of 462) with videos related to
Sort By:
Page
of 47
American Journal of Physiology. Renal Physiology
|
August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice
Timothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
September 28, 2017
[Prediction of outcome in acute myeloid leukemia by measurement of WT1 expression as a basic marker of minimal residual disease]
N Zhao, H Wei, Y Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications
Timothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Chemical Science
|
February 3, 2015
Kinetically Selective Inhibitors of Histone Deacetylase 2 (HDAC2) as Cognition Enhancers
F F Wagner, Y-L Zhang, D M Fass, et al.
British Journal of Cancer
|
June 28, 2012
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer
N Zhao, M-K Ang, X-Y Yin, et al.
Plos One
|
June 7, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
Kathleen M C Sullivan, Marta Vilalta, Linda S Ertl, et al.
European Journal of Clinical Nutrition
|
January 29, 2015
Folic acid supplementation and dietary folate intake, and risk of preeclampsia
Y Wang, N Zhao, J Qiu, et al.
Physical Review Letters
|
May 27, 2014
New edge coherent mode providing continuous transport in long-pulse H-mode plasmas
H Q Wang, G S Xu, B N Wan, et al.
Nature
|
January 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
Masataka Amisaki, Abderezak Zebboudj, Hiroshi Yano, et al.
Nature
|
November 14, 2017
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P Balachandran, Marta Łuksza, Julia N Zhao, et al.
Page
of 47